Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteNo recent work listed

Masahiko Yano

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6361-8869; OpenAlex author ID A5009691281. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper

Papers 11

  1. Clinical implications of the serum CA19-9 level in "biological borderline resectability" and "biological downstaging" in the setting of preoperative chemoradia… Co-author DOI 10.1016/j.pan.2020.05.020↗
  2. The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic c… Co-author DOI 10.1016/j.clnesp.2019.06.003↗
  3. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk f… Co-author DOI 10.1016/j.surg.2018.06.047↗
  4. Phase I Trial Evaluating the Safety of Preoperative Gemcitabine/nab-Paclitaxel With Concurrent Radiation Therapy for Borderline Resectable Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001140↗
  5. FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1016/j.ejso.2017.03.015↗
  6. Preoperative Gemcitabine-based Chemoradiation Therapy for Borderline Resectable Pancreatic Cancer: Impact of Venous and Arterial Involvement Status on Surgical… Co-author DOI 10.1097/sla.0000000000001547↗
  7. Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on opera… Co-author DOI 10.1016/j.surg.2014.09.022↗
  8. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in predicting the pathologic response to preoperative chemoradiation therapy … Co-author DOI 10.1007/s00268-012-1775-x↗
  9. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Co-author DOI 10.1097/sla.0b013e31829b3ce4↗
  10. Perineural invasion and lymph node involvement as indicators of surgical outcome and pattern of recurrence in the setting of preoperative gemcitabine-based che… Last author DOI 10.1097/sla.0b013e31823d813c↗
  11. Preoperative chemoradiation reduces the risk of pancreatic fistula after distal pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2011.03.001↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hidenori Takahashi · 11 shared papers, 2011–2020 · strength 0.58
  2. Osamu Ishikawa · 10 shared papers, 2011–2020 · strength 0.51
  3. Masato Sakon · 6 shared papers, 2015–2020 · strength 0.38
  4. Hirofumi Akita · 6 shared papers, 2015–2019 · strength 0.37
  5. Hiroaki Ohigashi · 7 shared papers, 2011–2017 · strength 0.28
  6. Kunihito Gotoh · 5 shared papers, 2011–2015 · strength 0.16
  7. Tatsuya Ioka · 2 shared papers, 2013–2018 · strength 0.12
  8. Shinichiro Hasegawa · 1 shared paper, 2020 · strength 0.09
  9. Daisaku Yamada · 1 shared paper, 2020 · strength 0.09
  10. Shigeru Marubashi · 2 shared papers, 2013–2015 · strength 0.08
  11. Yasuhiko Tomita · 2 shared papers, 2012–2013 · strength 0.07
  12. Yasuhiro Fujiwara · 1 shared paper, 2017 · strength 0.06
  13. Yoshiyuki Fujiwara · 1 shared paper, 2015 · strength 0.04
  14. Hirotada Kittaka · 1 shared paper, 2013 · strength 0.04
  15. Yuichiro Doki · 1 shared paper, 2012 · strength 0.03
  16. Hidetoshi Eguchi · 1 shared paper, 2012 · strength 0.03
  17. Shigenori Nagata · 1 shared paper, 2012 · strength 0.03
  18. Satoaki Nakamura · 1 shared paper, 2011 · strength 0.02
  19. Hisataka Ogawa · 1 shared paper, 2011 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.